A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses
Comella, P. H.; Gonzalez-Kozlova, E.; Kosoy, R.; Charney, A.; Peradejordi, I.; Chandrasekar, S.; Tyler, S.; Wang, W.; Losic, B.; Zhu, J.; Hoffman, G. E.; Kim-Schulze, S.; Qi, J.; Patel, M.; Kasarskis, A.; SuarezFarinas, M.; Gumus, Z. H.; Argmann, C.; Merad, M.; Becker, C.; Beckmann, N.; Schadt, E. E.
Show abstract
IntroThe molecular mechanisms of chronic fatigue syndrome (CFS, or Myalgic encephalomyelitis), a disease defined by extreme, long-term fatigue, remain largely uncharacterized, and presently no molecular diagnostic test and no specific treatments exist to diagnose and treat CFS patients. While CFS has historically had an estimated prevalence of 0.1-0.5% [1], concerns of a "long hauler" version of Coronavirus disease 2019 (COVID-19) that symptomatically overlaps CFS to a significant degree (Supplemental Table-1) and appears to occur in 10% of COVID-19 patients[2], has raised concerns of a larger spike in CFS [3]. Here, we established molecular signatures of CFS and a corresponding network-based disease context from RNA-sequencing data generated on whole blood and FACs sorted specific peripheral blood mononuclear cells (PBMCs) isolated from CFS cases and non-CFS controls. The immune cell type specific molecular signatures of CFS we identified, overlapped molecular signatures from other fatiguing illnesses, demonstrating a common molecular etiology. Further, after constructing a probabilistic causal model of the CFS gene expression data, we identified master regulator genes modulating network states associated with CFS, suggesting potential therapeutic targets for CFS.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mapping the genetic landscape of disorders on the autoimmune-autoinflammatory continuum: potential implications for classification and treatment 93%
- High-dimensional analysis reveals abnormal B cell subsets associated with specific changes to circulating T and myeloid cell populations in patients with idiopathic inflammatory myopathies 93%
- Unravelling the shared genetic mechanisms underlying 18 autoimmune diseases using a systems approach 93%
Similar papers in this journal
- Impact of rare and common genetic variation in theInterleukin-1 pathway for human cytokine responses 93%
- Single cell sequencing analysis uncovers genetics-influenced CD16+monocytes and memory CD8+T cells involved in severe COVID-19 92%
- Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis 92%
Similar papers in this journal
- Nuclear receptor subfamily 4A signaling as a key disease pathway of CD1c+ dendritic cell dysregulation in systemic sclerosis 92%
- Aberrant naive CD4+ T Cell differentiation in systemic juvenile idiopathic arthritis is committed to B cell help 91%
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases 91%
Similar papers in this journal
- Compartmentalization and persistence of dominant (regulatory) T cell clones indicates antigen skewing in juvenile idiopathic arthritis 92%
- Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis 92%
- Transcriptome network analysis implicates CX3CR1-positive type 3 dendritic cells in non-infectious uveitis 92%
Similar papers in this journal
- Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis 93%
- Genetic Risk Factors for Severe and Fatigue Dominant Long COVID and Commonalities with ME/CFS Identified by Combinatorial Analysis 91%
- A modular framework for the development of targeted Covid-19 blood transcript profiling panels 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.